420 With CNW - Reports Confirm DEA Is Close To Reclassifying Marijuana


(MENAFN- Investor Brand Network) The U.S. Drug Enforcement Administration (DEA) is set to
change the classification of cannabis . The proposal, pending review by the White House Office of Management and Budget (OMB), acknowledges marijuana's medical potential and implies that it is less prone to abuse compared to other certain drugs. However, it does not advocate for the complete legalization of marijuana for recreational purposes.

The move, disclosed by anonymous sources familiar with the matter, signals a major policy change for the DEA and a shift in...

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text
CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:
/Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
...

CannabisNewsWire is powered by
IBN

MENAFN10052024000224011066ID1108199949


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.